{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T16:14:48Z","timestamp":1785428088396,"version":"3.56.0"},"posted":{"date-parts":[[2025,10,2]]},"group-title":"Immunology","reference-count":54,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.biorxiv.org\/about\/FAQ#license"}],"funder":[{"name":"National Institutes of Health P20","award":["GM119943"],"award-info":[{"award-number":["GM119943"]}]},{"name":"National Institutes of Health P30","award":["GM122732"],"award-info":[{"award-number":["GM122732"]}]},{"award":["841-20210959"],"award-info":[{"award-number":["841-20210959"]}],"id":[{"id":"https:\/\/ror.org\/02y6cph55","id-type":"ROR","asserted-by":"publisher"}]},{"name":"NIGMS University of Rhode Island","award":["0009351"],"award-info":[{"award-number":["0009351"]}]},{"name":"NIGMS University of Rhode Island","award":["10262021"],"award-info":[{"award-number":["10262021"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,10,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>\n                  Myeloid-derived suppressor cells (MDSCs) are a heterogeneous cell population and the immunosuppressive function of MDSCs has been well established in tumor microenvironment. Recent studies show that adoptive transfer of MDSCs can ameliorate collagen-induced inflammatory arthritis (CIA), a mouse model of human rheumatoid arthritis (RA). Src homology 2 domain- containing inositol polyphosphate 5-phosphatase 1 (SHIP1) was previously shown to regulate MDSC differentiation. In this study, we aimed to generate immunosuppressive MDSCs from mouse bone marrow (BM) through genetic modification combined with cytokine treatments, and to investigate the ability of these ex vivo induced BM-MDSCs to suppress inflammatory responses in the CIA mouse model of RA. We found that myeloid specific ablation of SHIP1 increased the ratio of MDSCs and enhanced their regulatory functions in cytokine induced BM culture. MDSCs from LysMcre:SHIP1\n                  <jats:sup>flox\/flox<\/jats:sup>\n                  mouse BM culture demonstrated stronger inhibitory effect on T cell proliferation than those from control mouse BM. Ex vivo induced MDSCs from either control mice or mice with myeloid specific ablation of SHIP1 were administered to the CIA mice as a cell-based therapy to treat inflammatory arthritis. Adoptive transfer of either BM-MDSCs significantly reduced disease incidence and severity, but SHIP1 deficient BM-MDSCs exhibited even higher efficacy compared to wild-type BM-MDSCs. Furthermore, pharmacological inhibition of SHIP1 enhanced the expression of immune regulatory genes in BM-derived MDSCs, and adoptive transfer of these cells protected against CIA development. In conclusion, myeloid specific ablation of SHIP1 boosts ex vivo expansion and immune regulatory function of MDSCs in experimental inflammatory arthritis. These ex vivo generated BM-MDSCs may provide novel therapeutic opportunities for the treatment of RA and other inflammatory diseases.\n                <\/jats:p>","DOI":"10.1101\/2025.09.30.679529","type":"posted-content","created":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T22:00:14Z","timestamp":1759442414000},"source":"Crossref","is-referenced-by-count":1,"title":["Myeloid Specific Ablation of SHIP1 Boosts ex vivo Expansion and Regulatory Function of Myeloid-Derived Suppressor Cells in Inflammatory Arthritis"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2688-2681","authenticated-orcid":false,"given":"Eui Young","family":"So","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4145-794X","authenticated-orcid":false,"given":"Moon Jung","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2217-9908","authenticated-orcid":false,"given":"Young Eun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bedia","family":"Akosman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Euy-Myoung","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony M.","family":"Reginato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olin D.","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2025100606351192000_2025.09.30.679529v1.1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/41.3.329"},{"key":"2025100606351192000_2025.09.30.679529v1.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60008-8"},{"key":"2025100606351192000_2025.09.30.679529v1.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2012.05.021"},{"key":"2025100606351192000_2025.09.30.679529v1.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2012.02.005"},{"key":"2025100606351192000_2025.09.30.679529v1.5","doi-asserted-by":"crossref","unstructured":"Tu J , Huang W , Zhang W , Mei J , Zhu C : Two Main Cellular Components in Rheumatoid Arthritis: Communication Between T Cells and Fibroblast-Like Synoviocytes in the Joint Synovium. Front Immunol 2022, 13:922111.","DOI":"10.3389\/fimmu.2022.922111"},{"key":"2025100606351192000_2025.09.30.679529v1.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2015.07.017"},{"key":"2025100606351192000_2025.09.30.679529v1.7","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.2147\/JIR.S395566","article-title":"New Classification of Rheumatoid Arthritis Based on Immune Cells and Clinical Characteristics","volume":"17","year":"2024","journal-title":"J Inflamm Res"},{"key":"2025100606351192000_2025.09.30.679529v1.8","doi-asserted-by":"publisher","DOI":"10.1038\/nri2506"},{"key":"2025100606351192000_2025.09.30.679529v1.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2014.04.003"},{"key":"2025100606351192000_2025.09.30.679529v1.10","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-1299"},{"key":"2025100606351192000_2025.09.30.679529v1.11","doi-asserted-by":"publisher","DOI":"10.1016\/S1471-4906(03)00132-7"},{"key":"2025100606351192000_2025.09.30.679529v1.12","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0103010"},{"key":"2025100606351192000_2025.09.30.679529v1.13","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1203535"},{"key":"2025100606351192000_2025.09.30.679529v1.14","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.4A0314-139R"},{"key":"2025100606351192000_2025.09.30.679529v1.15","doi-asserted-by":"publisher","DOI":"10.1111\/nyas.12038"},{"key":"2025100606351192000_2025.09.30.679529v1.16","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.173.12.7324"},{"key":"2025100606351192000_2025.09.30.679529v1.17","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.176.7.3958"},{"key":"2025100606351192000_2025.09.30.679529v1.18","doi-asserted-by":"publisher","DOI":"10.1084\/jem.191.5.781"},{"key":"2025100606351192000_2025.09.30.679529v1.19","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.12.8777"},{"issue":"5","key":"2025100606351192000_2025.09.30.679529v1.20","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.3892\/or.2014.3435","article-title":"SHIP1 is targeted by miR-155 in acute myeloid leukemia","volume":"32","year":"2014","journal-title":"Oncol Rep"},{"key":"2025100606351192000_2025.09.30.679529v1.21","doi-asserted-by":"publisher","DOI":"10.1186\/ar4531"},{"key":"2025100606351192000_2025.09.30.679529v1.22","doi-asserted-by":"crossref","unstructured":"Yan L , Liang M , Yang T , Ji J , Jose Kumar Sreena GS, Hou X, Cao M, Feng Z: The Immunoregulatory Role of Myeloid-Derived Suppressor Cells in the Pathogenesis of Rheumatoid Arthritis. Front Immunol 2020, 11:568362.","DOI":"10.3389\/fimmu.2020.568362"},{"issue":"2","key":"2025100606351192000_2025.09.30.679529v1.23","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/15384047.2018.1523846","article-title":"Loss of lipid phosphatase SHIP1 promotes macrophage differentiation through suppression of dendritic cell differentiation","volume":"20","year":"2019","journal-title":"Cancer Biol Ther"},{"issue":"3","key":"2025100606351192000_2025.09.30.679529v1.24","doi-asserted-by":"crossref","first-page":"C569","DOI":"10.1152\/ajpcell.00433.2020","article-title":"Inhibition of lipid phosphatase SHIP1 expands myeloid-derived suppressor cells and attenuates rheumatoid arthritis in mice","volume":"321","year":"2021","journal-title":"Am J Physiol Cell Physiol"},{"issue":"11","key":"2025100606351192000_2025.09.30.679529v1.25","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41584-019-0285-8","article-title":"Bedside to bench: defining the immunopathogenesis of psoriatic arthritis","volume":"15","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"2025100606351192000_2025.09.30.679529v1.26","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-41534-1"},{"issue":"4","key":"2025100606351192000_2025.09.30.679529v1.27","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/art.39007","article-title":"Tofacitinib facilitates the expansion of myeloid-derived suppressor cells and ameliorates arthritis in SKG mice","volume":"67","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2025100606351192000_2025.09.30.679529v1.28","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.3682"},{"key":"2025100606351192000_2025.09.30.679529v1.29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23763-z"},{"key":"2025100606351192000_2025.09.30.679529v1.30","doi-asserted-by":"crossref","unstructured":"Yang G , Kramer MG , Fernandez-Ruiz V , Kawa MP , Huang X , Liu Z , Prieto J , Qian C : Development of Endothelial-Specific Single Inducible Lentiviral Vectors for Genetic Engineering of Endothelial Progenitor Cells. Sci Rep 2015, 5:17166.","DOI":"10.1038\/srep17166"},{"key":"2025100606351192000_2025.09.30.679529v1.31","doi-asserted-by":"crossref","unstructured":"Bronte V , Brandau S , Chen SH , Colombo MP , Frey AB , Greten TF , Mandruzzato S , Murray PJ , Ochoa A , Ostrand-Rosenberg S et al: Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards. Nat Commun 2016, 7:12150.","DOI":"10.1038\/ncomms12150"},{"key":"2025100606351192000_2025.09.30.679529v1.32","doi-asserted-by":"publisher","DOI":"10.1101\/gad.12.11.1610"},{"issue":"5","key":"2025100606351192000_2025.09.30.679529v1.33","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/mi.2012.29","article-title":"Myeloid cell-specific expression of Ship1 regulates IL-12 production and immunity to helminth infection","volume":"5","year":"2012","journal-title":"Mucosal Immunol"},{"key":"2025100606351192000_2025.09.30.679529v1.34","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201142092"},{"key":"2025100606351192000_2025.09.30.679529v1.35","doi-asserted-by":"publisher","DOI":"10.1038\/gene.2014.9"},{"key":"2025100606351192000_2025.09.30.679529v1.36","doi-asserted-by":"publisher","DOI":"10.1101\/gad.13.7.786"},{"key":"2025100606351192000_2025.09.30.679529v1.37","doi-asserted-by":"crossref","unstructured":"Lee CR , Lee W , Cho SK , Park SG : Characterization of Multiple Cytokine Combinations and TGF-beta on Differentiation and Functions of Myeloid-Derived Suppressor Cells. Int J Mol Sci 2018, 19(3).","DOI":"10.3390\/ijms19030869"},{"key":"2025100606351192000_2025.09.30.679529v1.38","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1500567"},{"key":"2025100606351192000_2025.09.30.679529v1.39","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1200086"},{"key":"2025100606351192000_2025.09.30.679529v1.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2015.02.001"},{"key":"2025100606351192000_2025.09.30.679529v1.41","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-205508"},{"key":"2025100606351192000_2025.09.30.679529v1.42","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2010.05869.x"},{"key":"2025100606351192000_2025.09.30.679529v1.43","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-09-181164"},{"key":"2025100606351192000_2025.09.30.679529v1.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.05.018"},{"key":"2025100606351192000_2025.09.30.679529v1.45","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2007.173"},{"key":"2025100606351192000_2025.09.30.679529v1.46","doi-asserted-by":"publisher","DOI":"10.1177\/0300985815588612"},{"issue":"8","key":"2025100606351192000_2025.09.30.679529v1.47","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1517\/14712598.2011.592825","article-title":"Abatacept: a biologic immune modulator for rheumatoid arthritis","volume":"11","year":"2011","journal-title":"Expert Opin Biol Ther"},{"key":"2025100606351192000_2025.09.30.679529v1.48","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-051113-024537"},{"key":"2025100606351192000_2025.09.30.679529v1.49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0030275"},{"key":"2025100606351192000_2025.09.30.679529v1.50","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S139248"},{"key":"2025100606351192000_2025.09.30.679529v1.51","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0902844"},{"key":"2025100606351192000_2025.09.30.679529v1.52","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2018.09.092"},{"key":"2025100606351192000_2025.09.30.679529v1.53","doi-asserted-by":"publisher","DOI":"10.1242\/dev.137075"},{"issue":"11","key":"2025100606351192000_2025.09.30.679529v1.54","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1038\/s41375-021-01249-7","article-title":"Myeloid-derived suppressor cell subtypes differentially influence T-cell function, T-helper subset differentiation, and clinical course in CLL","volume":"35","year":"2021","journal-title":"Leukemia"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2025.09.30.679529","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T09:42:59Z","timestamp":1768470179000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/2025.09.30.679529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,2]]},"references-count":54,"URL":"https:\/\/doi.org\/10.1101\/2025.09.30.679529","relation":{},"subject":[],"published":{"date-parts":[[2025,10,2]]},"subtype":"preprint"}}